Novo Nordisk Shares Plunge on Insulin's FDA Failure

Feb. 11 (Bloomberg) -- Bloomberg's Caroline Hyde reports that Novo Nordisk shares have fallen the most in a decade as the company's new insulin drug Tresiba has failed to win FDA approval in the United States. She speaks on Bloomberg Television's "The Pulse."
Cuban Envoy Says Progress Made on Normalizing U.S. Ties
32:25 - Feb. 27 -- Cuban Director of U.S. Policy Josefina Vidal speaks about negotiations on normalizing diplomatic relations between the U.S. and Cuba. She speaks at a news conference in Washington.
  • Remembering Former AIG CEO Bob Benmosche
  • House of Cards Season 3 Now on Netflix
  • Is America Facing a Third War in Iraq?